| Autor: |
LIU Jialong, HUANG Deng, CAO Li, WANG Xiaojun, LI Jianwei |
| Jazyk: |
čínština |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
Di-san junyi daxue xuebao, Vol 41, Iss 5, Pp 467-472 (2019) |
| Druh dokumentu: |
article |
| ISSN: |
1000-5404 |
| DOI: |
10.16016/j.1000-5404.201811005 |
| Popis: |
Objective To compare the perioperative and postoperative survival outcomes of laparoscopic hepatectomy (LH) and radiofrequency ablation (RFA) in the treatment of recurrent hepatocellular carcinoma (RHCC) in order to provide high-level evidence-based medical evidence for the treatment. Methods From September 2016 to September 2017, a total of 80 RHCC patients were prospectively enrolled and randomly assigned to the LH and RFA groups. A prospective randomized controlled study was used to analyze perioperative factors, overall survival and disease-free survival of patients between the 2 groups, and COX proportional risk model was used to analyze the risk factors for postoperative recurrence. Results According to this interim follow-up analysis, there was no significant difference in the overall survival time between the LH group and the RFA group (19.3±6.8 vs 18.6±6.2 months, P=0.293). The 1- and 2-year overall survival rates were 92.3% and 89.7% in the LH group and 85.4% and 80.5% in the RFA group. There was statistical significant difference in disease-free survival time between the LH group and the RFA group (16.4±8.5 vs 8.3±7.2 months, P=0.000). The 1-year and 2-year disease-free survival rates were 69.2% and 51.3% in LH group, and 26.8% and 22.0% in RFA group. COX proportional risk model analysis showed that the surgical procedures and preoperative alpha fetoprotein (AFP) level were the risk factors for re-recurrence. Conclusion Our interim follow-up analysis shows that, in selective RHCC patients, LH has a better 2-year disease-free survival rate than RFA. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
